“We firmly assume that from next year there will be vaccines for all age groups, even approved up to newborns,” said the Munich pediatrician Florian Hoffmann, senior physician at the children’s clinic of the Ludwig Maximilians University, the newspapers of the Funke media group . Vaccines for children under the age of twelve can be expected by the end of this year, it said.
The US vaccine manufacturer Moderna has meanwhile submitted initial data to the US FDA for the examination of a booster vaccination. It evokes a robust antibody response to the Delta variant, according to Moderna boss Stephane Bancel. The company also wants to transmit the data to the European authority EMA. In mid-August, the FDA approved the booster vaccination for people with weakened immune systems.
Jane Stock is a technology author, who has written for 24 Hours World. She writes about the latest in technology news and trends, and is always on the lookout for new and innovative ways to improve his audience’s experience.
